These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9636612)

  • 21. Tacrolimus (FK506) proves superior to OKT3 for treating episodes of persistent rejection following intrathoracic transplantation.
    Meiser BM; Uberfuhr P; Schulze C; Fuchs A; Mair H; Reichenspurner H; Kreuzer E; Reichart B
    Transplant Proc; 1997; 29(1-2):605-6. PubMed ID: 9123150
    [No Abstract]   [Full Text] [Related]  

  • 22. Standard cyclosporine A-based versus completely steroid-free FK506-based immunosuppression after liver transplantation.
    Pirenne J; Aerts R; Koshiba T; Van Gelder F; Roskams T; Nevens F; Fevery J
    Transplant Proc; 2001; 33(1-2):1505. PubMed ID: 11267396
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical trial of FK506 in heart transplant patients in Taiwan: report of 7 cases with immunosuppression switch from cyclosporine to FK506.
    Ko WJ; Chou NK; Chen YS; Hsu RB; Wang SS; Chu SH
    Transplant Proc; 1998 Nov; 30(7):3339-41. PubMed ID: 9838474
    [No Abstract]   [Full Text] [Related]  

  • 24. Early steroid withdrawal after liver transplantation.
    Ramirez CB; Sebayel MI; Kizilisik T
    Transplant Proc; 1998 Nov; 30(7):3182-3. PubMed ID: 9838406
    [No Abstract]   [Full Text] [Related]  

  • 25. Histopathological findings in heart transplant patients under tacrolimus-mycophenolate mofetil versus cyclosporine microemulsion-azathioprine.
    Sgrosso JL; Ferrer J; Araujo G; Romeo L; Parisi C; Vázquez MC
    Transplant Proc; 2002 Feb; 34(1):115-6. PubMed ID: 11959214
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical outcomes associated with conversion to tacrolimus-based immunosuppression in pediatric cardiac transplantation.
    Walker RE; McCrindle BW; Coles JG; West LJ
    Transplant Proc; 1998 Jun; 30(4):1116-7. PubMed ID: 9636452
    [No Abstract]   [Full Text] [Related]  

  • 27. Conversion from tacrolimus to microemulsion formulation of cyclosporine in pediatric liver transplantation.
    Alberti D; Reding R; Otte JB; Falchetti D; Rigamonti W; Caccia G; Sokal E; de Ville de Goyet J
    Transplant Proc; 1998 Aug; 30(5):1858-60. PubMed ID: 9723310
    [No Abstract]   [Full Text] [Related]  

  • 28. A randomized controlled trial of tacrolimus versus cyclosporine after lung transplantation.
    Hachem RR; Yusen RD; Chakinala MM; Meyers BF; Lynch JP; Aloush AA; Patterson GA; Trulock EP
    J Heart Lung Transplant; 2007 Oct; 26(10):1012-8. PubMed ID: 17919621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A large, multicentre trial to compare the efficacy and safety of tacrolimus with cyclosporine microemulsion following renal transplantation.
    Sperschneider H;
    Transplant Proc; 2001; 33(1-2):1279-81. PubMed ID: 11267291
    [No Abstract]   [Full Text] [Related]  

  • 30. Results with histological diagnosis in kidney transplant rejections treated with 15-deoxyspergualin.
    Kyo M; Ichikawa Y; Hanafusa T; Fukunishi T; Nagano S; Takahara S; Kokado Y; Okuyama A; Ihara H; Ito K; Sagawa S; Sonoda T; Akiyama T; Kurita T; Suzuki S; Amemiya H
    Transplant Proc; 1996 Apr; 28(2):910-1. PubMed ID: 8623457
    [No Abstract]   [Full Text] [Related]  

  • 31. Tacrolimus for steroid- and OKT3-resistant rejection in kidney recipients.
    Kliem V; Petersen R; Ehlerding G; Schaumann D; Eisenberger U; Koch KM; Pichlmayr R; Brunkhorst R
    Transplant Proc; 1998 Jun; 30(4):1251-3. PubMed ID: 9636509
    [No Abstract]   [Full Text] [Related]  

  • 32. Chronic rejection after orthotopic liver transplantation is increased under induction therapy with interleukin-2 receptor antibody BT563.
    Langrehr JM; Lohmann R; Raakow R; Jonas S; Klupp J; Bechstein WO; Neuhaus R; Neuhaus P
    Transplant Proc; 2001 May; 33(3):2290-1. PubMed ID: 11377531
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical experience with Prograf (tacrolimus, FK 506) in Chinese patients after renal transplantation.
    Yu L; Wang Y; Fu SJ; Cheng XJ
    Transplant Proc; 2000 Nov; 32(7):1709-10. PubMed ID: 11119902
    [No Abstract]   [Full Text] [Related]  

  • 34. Tacrolimus therapy for ABO-incompatible kidney transplantation.
    Takahashi K; Saito K; Sonda K; Nakagawa Y; Katagiri A; Tomita Y; Tanigawa T; Takeda M
    Transplant Proc; 1998 Jun; 30(4):1219-20. PubMed ID: 9636495
    [No Abstract]   [Full Text] [Related]  

  • 35. Use of FK506 as primary or rescue therapy after liver transplantation in Hong Kong.
    Lo CM; Fan ST; Liu CL; Chan KL; Ng IO; Lai CL; Lau GK; Fung SK; Wong J
    Transplant Proc; 1998 Nov; 30(7):3587-8. PubMed ID: 9838571
    [No Abstract]   [Full Text] [Related]  

  • 36. Tacrolimus therapy for persistent or recurrent acute rejection after lung transplantation.
    Horning NR; Lynch JP; Sundaresan SR; Patterson GA; Trulock EP
    J Heart Lung Transplant; 1998 Aug; 17(8):761-7. PubMed ID: 9730424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimization of the immunosuppressive protocol after lung transplantation.
    Reichenspurner H; Kur F; Treede H; Meiser BM; Deutsch O; Welz A; Vogelmeier C; Schwaiblmair M; Müller C; Fürst H; Briegel J; Reichart B
    Transplantation; 1999 Jul; 68(1):67-71. PubMed ID: 10428269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved immunosuppression with combination tacrolimus (FK506) and mycophenolic acid in orthotopic liver transplantation.
    Cai TH; Esterl RM; Nichols L; Cigarroa F; Speeg KV; Halff GA
    Transplant Proc; 1998 Jun; 30(4):1413-4. PubMed ID: 9636572
    [No Abstract]   [Full Text] [Related]  

  • 39. Tacrolimus versus cyclosporine as primary prophylactic therapy after cadaveric renal transplant: two-year survival study.
    Wong KM; Cheung CY; Chan YH; Chak WL; Choi KS; Chau KF; Li CS
    Transplant Proc; 2000 Nov; 32(7):1721-2. PubMed ID: 11119907
    [No Abstract]   [Full Text] [Related]  

  • 40. Improved survival after lung transplantation in patients treated with tacrolimus/mycophenolate mofetil as compared with cyclosporine/azathioprine.
    Izbicki G; Shitrit D; Aravot D; Sulkes J; Saute M; Sahar G; Kramer MR
    Transplant Proc; 2002 Dec; 34(8):3258-9. PubMed ID: 12493439
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.